- Sarepta Therapeutics to Restructure, Lay Off 500 Workers The Wall Street Journal
- Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta Therapeutics
- Sarepta Stock Soars 30%. Why Layoffs and a ‘Black-Box’ Warning Are Good News. Barron’s
- Sarepta Soars as Gene Therapy Stays on Market With Warning Bloomberg
- Sarepta Tags DMD Gene Therapy Elevidys With Black Box Warning, Axes 500 Staff BioSpace
Source link